Crossmark

Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients

Crossref DOI link: https://doi.org/10.1007/s11845-021-02884-w

Published Online: 2022-01-27

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Ningjie

Chen, Jiao https://orcid.org/0000-0002-5725-6440
License Information

Text and Data Mining valid from 2022-01-27

Version of Record valid from 2022-01-27
More Information

Article History

Received: 3 November 2021

Accepted: 7 December 2021

First Online: 27 January 2022

Declarations

:

: The study was approved by the Institutional Review Board.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below